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Heparin binding protein-44 (HBP-44) is a heparin binding protein of 44 kDa, found by
cDNA cloning using antibodies against teratocarcinoma glycoproteins [Furukawa, T. et al.
• (1990) J. Biochem. 108, 297-302]. The N-terminal sequence analysis reported in this
publication establishes the structure of its mature form. Immunohistochemical staining
revealed that HBP-44 was located in the tubular brush border of the kidney. HBP-44 formed
a complex with brushin, a high molecular weight (460 kDa) glycoprotein antigen common
to the kidney and teratocarcinoma, but not with OR8 antigen, another antigen (350 kDa) of
the same category. Brushin was shown to be the mouse counterpart of rat Heymann
nephritis antigen, called gp330. The association between HBP-44 and brushin was revealed
not only by co-precipitation upon indirect immunoprecipitation, but also by ligand
blotting with HBP-44-maltose binding protein fusion protein. Calcium ion stabilized the
association. Disulfide bonds in brushin seemed to be necessary for the complex formation,
since reductive cleavage of the bonds resulted in failure of the protein to associate with
HBP-44 in a ligand blotting experiment. Association of HBP-44 with brushin occurred both
interatocarcinomacells, in which these molecules are mainly located in extraembryonic
endoderm cells, and in the kidney, suggesting that the complex has an unknown common
function in the renal tubular brush border and the extraembryonic endoderm.

Differentiation antigens, which are selectively expressed in
certain differentiated cells or in subpopulations of cells in
the intermediate stage of differentiation, serve as useful
markers in cell identification and separation. Furthermore,
these antigens may reflect functional characteristics of the
positive cells, particularly in the cell surface, giving clues to
analyze specific cell functions in mature and differentiating
cells. Among many differentiation antigens found in the
mouse teratocarcinoma system, several are also expressed
in the kidney (1-5).
Heparin binding protein-44 (HBP-44), one such antigen,
is a 44 kDa heparin binding protein found by cDNA cloning
using antibodies against glycoproteins from teratocarcinoma cells (5). HBP-44 mRNA is intensely expressed in
the kidney and the extraembryonic endoderm cells of
teratocarcinomas (5). A 39 kDa human protein subse-

quently identified (RAP, receptor-associated protein) has
77% amino acid identity with HBP-44 (6), and is probably
the human homolog of HBP-44.
Brushin is defined by polyclonal antibodies raised against
teratocarcinoma glycoproteins which bind to a lectin,
Dolichos biflorus agglutinin (DBA) (3). 0R8 antigen is
defined by a monoclonal antibody raised against RCA
(Ricinus communis agglutinin)-binding glycoproteins from
murine teratocarcinomas (4). Brushin and 0R8 antigen are
expressed in the visceral endoderm and the renal tubular
brush border, and are of high molecular weight (4).
Furthermore, renal distribution of a high molecular weight
glycoprotein of the rat, gp330 (7, 8), which is a causative
antigen of an experimental autoimmune nephritis called
Heymann nephritis (9), is similar to brushin and 0R8
antigen. Although we observed no immunological cross
reaction between HBP-44 and brushin, a partial protein
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Association of HBP-44 with Brushin

MATERIALS AND METHODS

Cells and Tumors—PYS-2 cells and teratocarcinoma
OTT6050 were cultured or maintained as described previously (5).
Primer Extension—Primer extension was performed as
described previously (5).
Fusion Proteins—Protein A-HBP-44 fusion protein was
prepared as follows. The plasmid clone pO20 (5) was
digested with EcoBI, blunt-ended with Klenow fragment,
and then digested with Pstl. The fragment was subcloned
into the Smal-Pstl site of a protein A fusion protein vector
pRIT2T (Pharmacia), and the recombinant plasmid was
introduced into Escherichia coli N4830-1 cells. The bacterial culture and the purification of the fusion protein were
performed as described previously (11).
For producing maltose binding protein (MBP)-HBP-44
fusion protein, EcoBl-Pstl fragment of pO20 was subcloned into an MBP fusion protein vector, pMAL-cRI
(Bio-Labs). E. coli TB1 cells were transformed with the
recombinant plasmid, which encodes the fusion protein.
The cells were cultured, induced for fusion protein production, and coDected according to the protocol of the producer
(Bio-Labs). The collected cell pellet was suspended in
Dulbecco's phosphate-buffered saline without Ca2+ and
Mg2* [PBS( —)] and disrupted by sonication. After
centrifugation of the sonicate at 20,000 x g for 30 min, the
supernatant was applied to a column of amylose-resin
(Bio-Labs) (column volume = l m l ) , and the column was
washed with 5-10 column volumes of PBS( —) containing
0.1% Tween 20 and with P B S ( - ) successively. The fusion
protein was eluted with 10 mM maltose in PBS( —). About
10 mg of fusion protein was obtained from 1 liter of
bacteria culture solution.
Antibodies—Rabbit anti-brushin antibodies and rat OR8
monoclonal antibodies were prepared as described previously (3, 4).
Isolation of rat gp330 and preparation of anti-gp330
antibodies were performed as follows. Renal tubular
membrane fraction was prepared as described previously
(12), and subjected to preparative SDS-PAGE (5% gel,
under non-reducing conditions). The separation of gp330
from the other proteins including maltase was confirmed by
Coomassie Blue staining. Proteins in the gel were then
transferred electrophoretically to a nitrocellulose membrane and the position of gp330 was identified by Western
blotting using sera of Heymann nephritis rats, which
contain anti-gp330 autoantibodies. Most of the gp330 in the
gel was not transferred to nitrocellulose membrane because
of its size. A piece of the gel containing gp330 was collected
and this isolation of gp330 was repeated. The gel (4 ml)
containing gp330 was then homogenized in 4 ml of PBS and
mixed with 8 ml of Freund's complete adjuvant. Rabbits
were immunized with the mixture and boosted twice, 4 and
9 weeks later, with the antigen in Freund's incomplete
adjuvant. The animals were bled several times 1 to 3 weeks
after the last injection and the presence of antibodies was
determined by enzyme immunoassay. Upon Western
blotting, the antibody prepared by this method reacted to
only one band with a molecular weight of 440-450 kDa,
which showed identical mobility to that of the antigen
reacting to anti-gp330 monoclonal antibody (13).
Vol. 114, No. 3, 1993
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Anti-HBP-44 antibodies were prepared as follows. New
Zealand White rabbits were immunized with 100 uS of the
protein A-HBP-44 fusion protein which had been mixed
with an equal volume of Freund's complete adjuvant and
given 3 booster injections at 2-week intervals. Ten days
after the last injection, the rabbits were bled and antisera
were collected. For affinity purification of antibodies, 1 mg
of MBP-HBP-44 fusion protein was coupled to 1 ml of
CNBr activated Sepharose (14). The antisera were applied
to the MBP-HBP-44 column. After washing of the column
with 10-20 column volumes of PBS( —), specific antibodies
bound to the column were eluted with 0.1 M glycine-HCl
buffer, pH 2.5, and immediately neutralized with 1.5 M
Tris-HCl buffer, pH 8.8. The antibody concentration of the
eluate was 0.4 mg/ml.
Immunohistochemistry—For cryostat sections, the specimen was frozen in dry ice-acetone, cut into 4 ^ m slices with
a cryostat, and fixed with acetone. Endogenous peroxidase
activity was blocked by treatment of the sections with
methanol containing 0.3% H2O2. The section were treated
first with anti-HBP-44 antibodies [0.4 //g/ml in P B S ( - ) ]
at room temperature overnight and then with peroxidaseconjugated goat anti-rabbit IgG (Jackson) diluted 100-fold
with PBS( —) at room temperature for 1 h. The sections
were washed in PBS( —) between incubations. The reaction
products were visualized by reaction with a solution of
diaminobenzidine (15).
Immunoprecipitation—Up to 1 g of murine organs or
teratocarcinoma OTT6050 was homogenized in 4 ml of
P B S ( - ) containing 2 mM CaCl2 with a Polytron, and the
homogenate was centrifuged at 60,000 X g for 1 h. The
pellet was re-homogenized in 2% Triton X-100, 2 mM
CaCl2 in P B S ( - ) , and centrifuged at 60,000 X g for 30 min.
The supernatant (0.5 ml) was incubated with 200 //I of 20%
protein A Sepharose CL-4B (Pharmacia), which had been
washed with the washing buffer [0.1% Triton X-100, 2 mM
CaCl 2 ,1 mg/ml of ovalbumin in PBS (—)] for 15 min. After
centrifugation, the supernatant was incubated with 10 fig
of antibodies for 1 h, and immune complexes were collected
with 50 fxl of 20% protein A-Sepharose CL-4B. In the case
of OR8 antibodies, rabbit anti-rat IgG (Jackson) was used
as the second antibodies before incubation with protein
A-Sepharose. The resin was washed with the washing
buffer 3 times, then suspended in 50^1 of SDS-PAGE
sample buffer (16) and boiled for 5 min. After centrifugation, the supernatant was subjected to SDS-PAGE as
described by Laemmli (16) on a 4% gel, except that 2mercaptoethanol was omitted from the sample buffer, since
anti-gp330 antibodies and OR8 reacted only under nonreducing conditions.
Western Blot Analysis and the Analysis of the Association of HBP-44 with Immobilized Brushin—Western blot
analysis was carried out as described previously (5):
antigens reacted with rabbit or rat antibodies were visualized by reaction with horseradish peroxidase-conjugated
goat Fab anti-rabbit (or rat) IgG followed by 4-chloro-lnaphthol and H2O2 treatment.
To test the association of HBP-44 with immobilized
brushin, immunoprecipitate of the kidney with anti-gp330
antibodies was prepared as described under "Immunoprecipitation," subjected to SDS-PAGE, and transferred to a
nitrocellulose filter. The filter was incubated with MBPHBP-44 fusion protein or MBP (10 jig/ml each) in PBS( - )
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containing 2 mM CaCl2 and 4% skim milk for 2 h at room
temperature, followed by incubation with rabbit anti-MBP
antibodies (10 //g/ml) in the same buffer for 1 h at room
temperature. The bound antibodies were detected as
described previously (5), using peroxidase-conjugated goat
Fab anti-rabbit IgG.
Ca2+ Dependency of the Association of HBP-44 with
Brushin—Immunoprecipitation using anti-GP330 antibodies was performed as mentioned under "Immunoprecipitation" except that Tris-HCl buffer containing 5 mM
CaCl2 or 5 mM EGTA was used instead of PBS( - ) containing 2 mM CaCl2.
The effect of Ca2+ on the association of HBP-44 with
immobilized brushin was tested as follows. Immunoprecipitates of the kidney with anti-gp330 antibodies were
prepared as described above using Tris-HCl buffer (pH 7.4)
containing 5 mM CaCl2. After SDS-PAGE followed by
transfer to a nitrocellulose filter, the incubation of the filter
with MBP-HBP-44 or MBP, and antibodies was carried out
as mentioned above except that Tris-HCl buffer (pH 7.4)
containing 5 mM CaCl2 or 5 mM EGTA was used instead of
P B S ( - ) containing 2 mM CaCl2.
NH2-Terminal Sequence Analysis—HBP-44 was isolated
from RCA-agarose binding glycoproteins of teratocarcinoma OTT6050 (4) by immunoaffinity chromatography
using anti-HBP-44, performed essentially as described
before (3). After SDS-PAGE and transfer of the 44kDa
band to polyvinylidene difluoride membrane, the amino
acid sequence of HBP-44 was determined as described (17)
except that 8% gel was used and that transfer to the
membrane was performed in 25 mM Tris-HCl, 10 mM
glycine solution.
RESULTS

the kidney and teratocarcinoma OTT6050. After SDSPAGE and blotting with anti-brushin antibodies, two bands
(450 and 350 kDa) were detected in the preparation from
the teratocarcinoma (Fig. 3, lane 1). In the case of the
kidney, these two bands and a minor band just below the
450 kDa one were detected (lane 2). Anti-rat gp330 antibody reacted with the larger, predominant band both in the
kidney and teratocarcinoma (lanes 3 and 4). The minor
band just below the 450 kDa one was also reactive with
anti-gp330 and was considered to be a modified form of the
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Further Characterization of HBP-44—We performed
GTGCTGCTAGACACACTGACCAGAGCrcAAGAAGGTTATGAGAACCTTCTCAGTCCCTCG
662
primer extension to obtain a cDNA clone of HBP-44 with
V L L D T L S R A E E G Y E N L L S P S
210
the full coding sequence; the cDNA clones we previously
GACATGGCCC^CATCAAGAGCGACACCCTGATCAGCAAGCACAGTGAGCTGAAGGACAGA
722
analyzed had lacked initiator methionine (5). By screening
D M A H I K S D T L I S K H S E L K D R
230
a library constructed by primer extension, we isolated a
desired clone. The initiator methionine was found just one
CTGCGCACrrATCAACCAGGaTrTGGACCGCCTGCGGAAGGTCAGCCACCAGGGCTATGGC
782
L R S I N Q G L D R L R K V S H Q G Y G
250
amino acid residue on the N-terminal side from the
previously identified HBP-44 sequence (Fig. 1), and the Tca^CCACTGAGTTTGAAGAGCCCCGGGTGATACATCTGTGGGACCTGGCTCACrrCTGCC 8 4 2
position corresponded to that of human RAP (6). The result
S T T E F E E P R V I D L W D L A Q S A
270
is consistent with our previous conclusion that the cDNA
AACTTCACTGAGAAGGAACTGGAGTCATTCAGGGAGGAGCTCAAGCACTTTGAGGCCAAA
902
clone, which we analyzed, specifies a 44 kDa glycoprotein
N F T E K E L E S F R E E L K H F E A K
290
•
(5), not a 330 kDa glycoprotein as proposed by PietroATTGAAAAGCACAACCACTACCAGAAGCAGCTGGAGATTTCCCACCAGAAGCTGAAGCAC
960
monaco et al. (10).
I E K H N H Y Q K Q L E I S H Q K L K H
310
N-Terminal amino acid sequence analysis (Table I)
GTGGAGAGCATCGGCGACCCCGAGCACATCAGCCGCAACAAGGAGAAATACGTGCTGCTG
1022
revealed that HBP-44 had a signal peptide and that the
V E S I G D P E H I S R N K E K Y V L L
330
position of cleavage was between Lys37 and Tyr38, the same
as that of human RAP (6). The mature protein has a
GAGGAGAAGACCAAGGAGCTGGGCrACAAGGTGAAGAAGCATCTACAGGACCTGTCTAGC
1082
E E K T K E L G Y K V K r H L Q D L S S
350
molecular weight of 38,090, and considering the contribution of carbohydrate chains, this value is in agreement with
AGGGTCTCAAGGGCTCGGCACAATGAGCTCTGAGGACCAGAAGCCACCAGCAGCAGCCTA
1142
R V S R A R H N E L
360
the estimate of 44 kDa based on SDS-PAGE.
We then studied the distribution of HBP-44 in the kidney
1202
by immunohistochemical analysis. As shown in Fig. 2, GTt^CTGGTGTGGCTGACCACCGTGGCAAGGAGGATCCCTrGAAATACCAAGCrGATCCT 1262
ACAGTGGCTGGCAAGGACTT ATTTTCTCTCAAGCAAGTGTAGTTGTCACCACCCTGGACG
1322
HBP-44 was present on the brush border of the proximal
AGGGCCTTGGGTACCGCTACCAGTGAGATAGGACTGGACTCCGAGCTGCAGCACAACACT
1382
tubules and the inner surface of Bowman's capsules. This
TTATATTGAAATCACATAAACCTGCCTGCCACTGGAAACATTCTGTACACATCCTTAAAT
1442
distribution is similar to those of brushin (3) and OR8 ACATOK*GAGTrrTGAAAAAAAAAAAAAAAAAAAA
1478
antigen (4).
Fig. 1. Sequence of cDNA encoding HBP-44 and the deduced
Correlation between Brushin, 0R8 Antigen and gp330—
amino acid sequence. The signal sequence is underlined, and a
Brushin was isolated by indirect immunoprecipitation from
potential iV-glycosylation site is shown by an asterisk.
J. Biochem.
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TABLE I. N-terminal sequence analysis of HBP-44. Undefined
residues are represented as X.
11
4
7
10
12
Cycle No. 1
2
3
6
6
8
9
Amino
Tyr Ser X Glu Lys Asn X Pro Glu Met Ala Ala
acids

M.W.
(kd)
400-

%awj
200-

Fig. 4. Immunopreclpitation of the kidney, the liver, and
OTT6050 with anti-HBP-44 antibodies. The murine kidney (lane
1), liver (lane 2), or teratocarcinoma OTT6050 (lane 3) was solubilized with 2% Triton X-100, immunoprecipitated with anti-HBP-44
antibodies, and separated on 4% polyacrylamide gel. The gel was
stained with silver nitrate.

Fig. 2. The distribution of HBP-44 in the kidney. A frozen
section of the kidney was stained as described in "MATERIALS AND
METHODS." Bar: 5 0 M m .

B
M.W.
(kd) 1

2

2

3

4

M.W.
(kd)
400-

400-

200-

200-

Fig. 3. Correlation between brushin, OR8 antigen, and gp330.
Triton X-100 extracts from the kidney or teratocarcinoma OTT6050
were immunoprecipitated with rabbit anti-brushin antibodies, separated by SDS-PAGE under non-reducing conditions using 4% gel and
subjected to Western blot analysis with rabbit anti-brushin antibodies (lanes 1 and 2), rabbit anti-gp330 antibodies (lanes 3 and 4),
or OR8 monoclonal rat antibody (lanes 5 and 6). Lanes 1, 3, 5:
teratocarcinoma OTT6050; lanes 2, 4, 6: the kidney. Since final
detection depended on reaction with the first antibody, rabbit immunoglobulins (around 150 kDa) in the immunoprecipitates were
detected in lanes 1-4. Therefore the region above molecular weight
200 kDa is shown in the figure.

450 kDa component (lane 4). Thus, brushin which we had
previously identified was mainly composed of two components, the 450 and 350 kDa ones. The 450 kDa one is the
mouse counterpart of rat gp330. OR8 antibody did not react
with the 450 kDa band but reacted with the 350 kDa band
(lanes 5 and 6). Thereafter we will use the term brushin for
the major 450 kDa component, and the 350 kDa one will be
Vol. 114, No. 3, 1993

Fig. 5. The association of HBP-44 with brushin. A) Western
blot analysis of proteins co-precipitated with HBP-44 in the kidney.
The immunoprecipitate with anti-HBP-44 antibodies in the kidney
was analyzed by Western blotting using anti-gp330 antibodies (lane
1) or an OR8 monoclonal antibody (lane 2). B) Evidence that HBP-44
is directly associated with brushin. Brushin was immunoprecipitated
with anti-gp330 antibodies (lanes 1 and 3) or anti-HBP-44 antibodies
(lanes 2 and 4), separated by SDS-PAGE (4% gel), and transferred to
a nitrocellulose filter. The filter was incubated with MBP-HBP-44
fusion protein (lanes 1 and 2) or MBP (lanes 3 and 4). The association
was detected as described in 'MATERIALS AND METHODS.*
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called OR8 antigen.
HBP-44 Associates with Brushin Both in the Kidney and
the Teratocarcinoma—Although HBP-44/RAP associates
with a-2 MR/LRP, their patterns of tissue distribution do
not correlate with one another. a^MR/LRP is most highly
expressed in the liver, the lung and the brain (18). On the
other hand, HBP-44 is intensely expressed in the kidney
followed by the brain and the testis, but only weakly in the
liver (6). These data raise the possibility that in the kidney
HBP-44/RAP associates with a molecule different from a2
MR/LRP. To elucidate whether HBP-44 is associated with
a molecule different from a-2MR/LRP in the kidney, immunoprecipitation with anti-HBP-44 antibodies was performed using Triton X-100 extracts from the kidney, the
liver or OTT6050. A protein with a molecular weight of
about 450 kDa was co-precipitated with HBP-44 in the
kidney (Fig. 4, lane 1) and OTT6050 (lane 3), although a
smaller protein (about 380 kDa), was co-precipitated in the
liver (lane 2). The existence of HBP-44 in the immunoprecipitates was confirmed by Western blot analysis using
a higher concentration gel (data not shown). The co-precipitated protein in the liver was probably a2 MR/LRP, since it
has been reported that human <*2MR/LRP was co-precipitated with RAP under similar conditions (6).
When the 450 kDa protein co-precipitated with HBP-44
in the kidney was subjected to Western blot analysis with
rat anti-gp330 antibodies or OR8 antibodies, only antigp330 antibodies reacted with that protein (Fig. 5A). Thus,
the molecule associated with HBP-44 in the kidney was
brushin and not OR8 antigen. The same results were
obtained with teratocarcinoma OTT6050 (data not shown).
To exclude the possibility that brushin was co-precipitated with HBP-44 due to cross-reactivity to anti-HBP-44
antibodies, we tested whether HBP-44 associated with
immobilized brushin on the nitrocellulose membrane. A
ligand blotting experiment (Fig. 5B) shows that MBPHBP-44 fusion protein can associate with brushin on the
nitrocellulose membrane, although control MBP cannot.
This indicates that brushin was co-precipitated with
HBP-44 due to their association and not to cross-reactivity.
Effects of Ca2+ and the Reducing Agent on the Association of HBP-44 with Brushin—Since the binding of human
RAP to ff2MR/LRP requires Ca2+ (19), we tested the Ca2+
dependency of the association of HBP-44 with brushin.

1

2

Fig. 6. Requirements for association of
brushin with HBP-44. A, B) CaI+ dependency.
A: Lmmunoprecipitation of Triton X-100 extract in the presence of 5 mM CaCli (lane 1) or
5 mM EGTA (lane 2). The complex of brushin
and HBP-44 was collected by using anti-HBP44 antibodies from the kidney. The complex was
separated by SDS-PAGE and subjected to
Western blot analysis with anti-gp330 antibodies. B: Immobilised brash in was incubated
with MBP-HBP-44 fusion protein (lanes 1 and
2) or MBP (lanes 3 and 4) in the presence of 5
mM CaCl, (lanes 1 and 3) or 6 mM EGTA (lanes
2 and 4). C) The effect of a reducing agent.
Immunoprecipitated brushin was subjected to
SDS-PAGE in the absence (lane 1) or presence
(lane 2) of 2-mercaptoethanol. After transfer to
a filter, the filter was incubated with MBPHBP-44 fusion protein as in Fig. 5B.

When the immunoprecipitation was performed in the
presence of EGTA, the amount of co-precipitated brushin
significantly decreased, although the association was not
completely abolished (Fig. 6A). Similar results were
obtained when MBP-HBP-44 fusion protein was incubated
with immobilized brushin. In the ligand blotting experiment the binding of the fusion protein to brushin on the
membrane was drastically inhibited by EGTA (Fig. 6B).
When brushin was subjected to SDS-PAGE under reducing conditions and immobilized, HBP-44 could not associate
with the molecule (Fig. 6C). The result indicates that a rigid
structure of brushin preserved by disulfide bonds is required for binding to HBP-44.
DISCUSSION
We have presented evidence indicating that HBP-44
associates with brushin. A ligand blot experiment using
MBP-HBP-44 fusion protein established that HBP-44
directly associated with brushin. Furthermore, the method
enabled us to show that Ca2+ is involved in the association
and that disulfide linkage in brushin is required for the
association. Strictly speaking, immunoelectron microscopy
is required to show that the molecular complex is not
formed after detergent solubilization and that the two
molecules form a complex on the membrane plane. However, because of the similar tissue distributions of HBP-44
and brushin (Fig. 2 and Ref. 3), we believe that the
molecular complex is indeed present on the cell surface.
The relationship between brushin, gp330 and OR8
antigen was also clarified in the present investigation. The
brushin preparation previously analyzed contained two
polypeptides, a 450 kDa one and a 350 kDa one, of which
the former was the major antigenic component. The 450
kDa one was identical to gp330. Since the molecular weight
of this component is greater than 330 kDa and even higher
than that of laminin heavy chain (400 kDa under reducing
conditions) both in mouse and rat, we think the name gp330
may be inappropriate and in this publication we retain the
name of brushin for the 450 kDa component. The 350 kDa
component is called OR8 antigen, because monoclonal
antibody 0R8 specifically reacts with it.
Pietromonaco et al. had reported a cDNA sequence for a
pathogenic domain of rat gp330 (10). However, since this
J. Biochem.
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sequence has a strong homology with murine HBP-44 and
human RAP, it is currently thought that the cloned cDNA
encodes the rat homologue of HBP-44/RAP. During preparation of our manuscript, they reported that rat gp330
co-precipitates with a 44 kDa protein and that the 44 kDa
protein is immunologically identical with human RAP (20).
However, direct evidence that gp330 interacts with HBP44 was not presented. It is not entirely clear why their
cDNA clone produced a protein antigenically related to
gp330; they mentioned the possibility that gp330 and the
44 kDa protein have a common antigenic domain (20).
When we performed Western blot analysis of Triton X-100
extract from the kidney with affinity-purified antibodies
raised against /?-galactosidase-HBP-44 fusion protein or
protein A-HBP-44 fusion protein, none of the antibodies
reacted with brushin (data not shown). It seems unlikely
that a common pathogenic domain exists, and it is certain
that the cDNA cloned by them (20) specifies rat HBP-44/
RAP, and not gp330.
On the other hand, Raychowdhury et aL isolated and
sequenced partial cDNAs for rat gp330. The deduced amino
acid sequence contained regions showing homology with
human LDL-receptor (21). Thus, LDL-receptor, a-2MR/
LRP, and brushin/gp330 may be members of the same
receptor family, and HBP-44/RAP associates with two of
them, «2MR/LRP and brushin/gp330. The HBP-44/RAP
binding sites have not been identified in o^MR/LRP or
brushin/gp330. However, since both ar2MR/LRP and
brushin/gp330 have similar cysteine-rich repeats (18, 21),
and since we reported here that reducing agents abolished
the association of HBP-44 with brushin, some of these
repeats might act as HBP-44/RAP binding sites. Furthermore, association of HBP-44 with brushin and a 2 MR/LRP
requires Ca2+ for stability.
The molecular complex formed from brushin and HBP44 is expected to be present on the tubular brush border in
the kidney, since both molecules are co-localized there by
immunohistochemistry. Brushin and HBP-44 also exist and
form a complex in teratocarcinoma OTT6050. When PYS-2
parietal endoderm cells were stained with anti-HBP-44
antibodies (5), or with anti-gp330 antibodies (data not
shown) both molecules showed similar distribution patterns. The same complex seems to exist in extraembryonic
endoderm cells of teratocarcinoma and most probably those
of embryos. Although the physiological functions of the
complex and a distinct molecule, OR8 antigen, are un-
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known, they may be involved in functions which are
common to the renal brush border and extraembryonic
endoderm cells, such as absorption of nutrients.
We thank Miss Kumiko Sato for her expert secretarial assistance.
REFERENCES
1. Johnson, L.D. & Warfel, J. (1976) Biochem. Biophys. Acta 455,
538-544
2. Ozawa, M., Yonezawa, S., Miyauchi, T., Sato, E., &Muramatsu,
T. (1982) Biochem. Biophys. Res. Commun. 105, 495-501
3. Ozawa, M., Yonezawa, S., Sato, E., & Muramatsu, T. (1982) Dev.
Biol. 91, 351-359
4. Ozawa, M., Yonezawa, S., Sato, M., Uehara, H., Sato, E., &
Muramatsu, T. (1987) Dev. Growth Differ. 29, 455-468
5. Furukawa, T., Ozawa, M., Huang, R.-P., &Muramatsu, T. (1990)
J. Biochem. 108, 297-302
6. Strickland, D.K., Ashcom, J.D., Williams, S., Battey, F., Behre,
E., McTigue, K., Battey, J.F., & Argraves, W.S. (1991) J. BioL
Chem 266, 13364-13369
7. Kerjaschki, D. & Farquhar, M.G. (1982) Proc. Natl Acad. Sci.
USA 79, 5557-5561
8. Kerjaschki, D. & Farquhar, M.G. (1983) J. Exp. Med. 157, 667686
9. Heymann, W., Hackel, D.B., Harwood, S., Wilson, S.G.F., &
Hunter, J.L.P. (1959) Proc. Soc. Exp. Biol. Med. 100, 660
10. Pietromonaco, S., Kerjaschki, D., Binder, S., Ullrich, R., &
Farquhar, M.G. (1990) Proc. Natl. Acad. Sci. USA 87, 18111815
11. Masuzawa, Y., Miyauchi, T., Hamanoue, M., Ando, S., Yoahida,
J., Takao, S., Shimizu, H., Adachi, M., & Muramatsu, T. (1992)
J. Biochem. 112, 609-615
12. Natori, T., Hayakawa, I., & Shibata, S. (1986) Lab. Invest 55,
63-70
13. Natori, T., Hayakawa, I., & Shibata, S. (1987) Clin. Exp.
ImmunoL 69, 33-40
14. Johnstone, A. & Thorpe, R. (1982) Immunochemistry in Practice,
Blackwell Scientific Publications, Oxford
15. Yonezawa, S., Tachikawa, T., Shin, S., & Sato, E. (1992) Am. J.
Clin. Pathol. 98, 167-174
16. Laemmli, U.K. (1970) Nature 227, 680-685
17. Matsudaira, P. (1987) J. Biol. Chem. 262, 10035-10038
18. Herz, J., Hamann, U., Rogne, S., Myklebost, 0., Gausepohl, H.,
& Stanley, K.K. (1988) EMBO J. 7, 4119-4127
19. Williams, S.E., Ashcom, J.D., Argraves, W.S., & Strickland,
D.K. (1992) J. Biol. Chem. 267, 9035-9040
20. Orland, R.A., Kerjaschki, D., Kurihara, H., Biemesderfer, D., &
Farquhar, M.G. (1992) Proc. Natl. Acad. Sci. USA 89, 66986702
21. Raychowdhury, R., Niles, J.L., McCluskey, R.T., & Smith, J.A.
(1989) Science 244, 1163-1165

